Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Sacubitril-Valsartan on Estimated Pulmonary Artery Systolic Pressure in Patients With Heart Failure With Reduced Ejection Fraction Heart Failure
Sponsor: Aswan University
Summary
Evaluate effect of Sacubitril-Valsartan on estimated pulmonary artery systolic pressure in patient with reduced ejection fraction heart failure
Official title: Effect of (Sacubitril-Valsartan) Drug on Estimated Pulmonary Artery Systolic Pressure
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
59
Start Date
2025-07-05
Completion Date
2026-07-12
Last Updated
2026-09-11
Healthy Volunteers
No
Conditions
Interventions
SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®)
sacubitril-Valsartan is ARNI that is one of the pillars of heart failure treatment, here we study its effect on estimated pulmonary artery systolic pressure and studying its effect on relieving elevated pulmonary pressure symptoms.
Locations (1)
Faculty of medicine- Aswan university
Aswān, Egypt